Cyclin D1 is a key regulator of cell proliferation. It also controls other aspects of the cell fate, such as cellular senescence, apoptosis and tumourigenesis. We used Blymphoid cell lines producing cyclin D1 to investigate the role of this protein in B-cell lymphomas and leukaemias. Constitutive low levels of cyclin D1 had no effect per se on cell proliferation, but conferred resistance to various apoptotic stimuli in B cells. Activation of the proapoptotic protein, Bax, was reduced and mitochondrial permeabilization and phosphatidylserine exposure following cytokine withdrawal were delayed in cyclin D1-producing cells. Proteomic analysis showed that the presence of cyclin D1 led to intracellular accumulation of various molecular chaperones. The chaperone, heat shock protein (Hsp)70, bound to both Bax and the mitochondrial apoptosis inducing factor following cytokine withdrawal, and impeded inhibitors of jB (IjB)-mediated inhibition of nuclear factor-jB anti-apoptotic signalling. Impairment of Hsp70 activity-using a pharmacological Hsp inhibitor or transfecting cells with an Hsp70-blocking antibody-restored the cellular response to mitochondrial apoptosis triggering. Thus, constitutive de-novo cyclin D1 production in B cells delays commitment to apoptosis by inducing Hsp70 chaperoning activity on pre-and post-mitochondrial pro-apoptotic factors.
Introduction
Cyclin D1, together with cyclin-dependent kinase (CDK) 4 and CDK6, promotes progression through the G 1 phase of the cell cycle by regulating retinoblastoma protein (pRb)/E2F function; this underlies its oncogenic potential in various cyclin D1-overexpressing solid tumours and haematological malignancies (Sherr, 1996; Diehl, 2002; Alao, 2007) . Breast, ovarian, bladder, oesophageal, stomach, laryngeal, lung and liver cancers show CCND1 gene amplification (Diehl, 2002; Ortega et al., 2002; Alao, 2007) . A reciprocal translocation t(11;14)(q13;q32), joining the cyclin D1-encoding sequences to an enhancer of the immunoglobulin heavychain locus, causes activation of CCND1 in mantle cell lymphoma and some cases of multiple myeloma (MM) (Seidl et al., 2003; Bertoni et al., 2004) . The mechanism of CCND1 activation is not yet characterized for other diseases, such as hairy cell leukaemia and other cyclin D1-producing MM (Krieger et al., 2005) . Cyclin D1, produced abnormally in B lymphocytes under pathophysiological conditions, is implicated in overcoming the suppressor effect of the tumour suppressor pRb or modifying the transcriptional regulation of target genes .
Previous studies have suggested a direct role of cyclin D1 in the regulation of cell susceptibility for the induction of apoptosis.
The intrinsic apoptotic pathway is activated by permeabilization of the outer mitochondrial membrane, which leads to cytosolic release of mitochondrial apoptogenic proteins involved either in caspasedependent (cytochrome c, Smac/DIABLO, Omi/HtrA2) or -independent (apoptosis-inducing factor (AIF), endonuclease G) cell death processing (Hengartner, 2000) . Mitochondrial integrity is controlled by the balance and interaction of Bcl-2 family members, including the prosurvival Bcl-2-like proteins and their pro-apoptotic counterparts, for example the multidomain Bax/Baklike group and the BH3-only proteins. BH3-only proteins function as sensors of cellular well-being and bind pro-survival factors, allowing Bax and Bak oligomerization and consequent permeabilization of the mitochondrial outer membrane following cellular injury (Adams and Cory, 2007) .
In a previous investigation of the role of cyclin D1 in the physiopathology of B-cell haemopathies, we generated BaF3-derived cell lines conditionally expressing cyclin D1 (Duquesne et al., 2001) . We now report that the BD1-A21 sub-clone, with constitutive low levels of cyclin D1, is less susceptible than the parental BaF3 cell line to apoptosis following treatment with anticancer drugs and growth factor deprivation. This phenotype is associated with intracellular accumulation of several molecular chaperones and the dual capacity of the 70 kDa Hsp70 to retain cytosolic release of the apoptosis modulators Bax and AIF, and promote nuclear factor (NF)-kB anti-apoptotic signalling.
Results

BD1-A21 cells exhibit the same proliferation properties as BaF3 cells
We previously characterized three distinct cell lines, generated by electroporation of BaF3 cells with a cyclin D1-expressing plasmid and selection (Duquesne et al., 2001) : basal cyclin D1 was almost absent in BD1-9 and inducible by hormonal treatment; cyclin D1 was produced at a basal level, and was still inducible in BD1-31 and the BD1-A21 cell line produced basal levels of cyclin D1, which was not inducible even by high concentrations of the ecdysone analogue, ponasterone A (Figure 1a ). BD1-A21 cells had similar proliferation curves to the parental BaF3 cell line, with almost the same doubling time (14 and 15 h, respectively), similar cloning efficiencies by limiting dilution and saturation densities (Figure 1b ; data not shown), despite producing a basal level of cyclin D1. Immunoblot analysis of cyclin D1 partners in cell-cycle regulation showed that cyclins A, B, E, D3 and CDK2/ 4/6 and the tumour suppressor p53 were present at similar levels in BD1-A21 and BaF3 cells (Figure 1c) . Thus, the presence of cyclin D1 did not affect the proliferation characteristics of BaF3.
BD1-A21 cells are resistant to drug-induced apoptosis
To test whether basal levels of cyclin D1 could modify the cellular response to common anti-cancer drugs, BaF3 and BD1-A21 cells were exposed to a panel of alkylating or DNA-damaging agents capable of inducing single-or double-strand DNA breaks in BaF3 cells (Palacios et al., 2000) . We compared the effects of mitomycine C (Mito), etoposide (Etop), cis-platinum (CDDP), doxorubicin (Dox), staurosporine (STS) and flavopiridol (Flavo), at different time intervals, between the two cell lines. BaF3 and BD1-A21 viability curves after CDDP, Dox, Mito and Flavo treatments were similar (Figure 2a ), whereas BD1-A21 cells showed a marked resistance to cell death after exposure to Etop or STS. At 12 h after Etop treatment, cell viability was 40% for BaF3 and 89% for BD1-A21; 6 h after STS treatment, cell viability was 53% for BaF3 and 91% for BD1-A21. In both cases, all cells were dead 48 h after Etop treatment and 24 h after STS treatment. Thus, apoptosis was induced by the appropriate signal in BD1-A21 cells, but was markedly delayed, as compared to the parental cell line. Flow cytometric analysis of DNA content showed that 12 h after treatment with both drugs, the number of cells in the sub-G 1 (that is, apoptotic) fraction was significantly higher in the BaF3 culture than in the BD1-A21 culture (Figure 2b ). The hypodiploid cell fraction (dying cells) after Etop and STS treatment represented 47 and 65% of BaF3 cells, but only 11 and 33% of BD1-A21 cultures, respectively. The difference in the rate of cells already dead (represented by the 'debris' fraction) following STS treatment was markedly different between the two cell lines: 51% of BaF3 cells and only 8% of BD1-A21 cells (data not shown). Overall, these findings show that cell death triggered by certain cytotoxic drugs was attenuated and delayed in cyclin D1-producing cells. Cyclin D1 expression confers partial resistance to apoptosis induced by growth factor requirement BaF3 cells are strictly dependent on interleukin-3 (IL-3) for survival and growth. Unlike for the cytotoxic stimuli used above, p53 is not required to induce apoptosis following IL-3 withdrawal (Canman et al., 1995; Silva et al., 1997) . IL-3 withdrawal is therefore a useful tool to induce cell death without interfering with p53 signalling. BD1-A21 cells underwent cell death at a much slower rate following IL-3 withdrawal than BaF3 cells, demonstrating marked resistance to cell death induction in these cells (Figure 3a, left panel) . At 72 h after IL-3 withdrawal, 68% of BD1-A21 and only 24% of BaF3 cells were still alive. When IL-3 was added back to the cells 6 h after cytokine withdrawal, the recovery of proliferation capacity was faster in BD1-A21 cells than in BaF3 cells (Figure 3a , right panel). Cell-cycle data ( Figure 3b ) revealed a similarly delayed response as that observed for cytotoxic drugs, with only 14% of BD1-A21 cells, but 24% of BaF3 cells, in the sub-G 1 fraction 24 h after IL-3 withdrawal. These results demonstrate BD1-A21 cell resistance to apoptosis, independent of p53 mobilization.
We characterized possible defects in the apoptotic pathway activated by IL-3 deprivation in BD1-A21. Both cell lines were cultured for 24 h in the absence of IL-3 and intrinsic apoptotic hallmarks were quantified by flow cytometry. The lower level of phosphatidylserine Cyclin D1 regulation of apoptosis G Roué et al (PS) exposure in BD1-A21 cells than that observed in BaF3 cells cultured without IL-3 (33.7 and 23.3%, respectively) was associated with a twofold lower mitochondrial depolarization, assayed by 3,3 0 -diexyloxacarbocyanine iodide (DiOC 6 (3)) incorporation (42.9 and 24.3%), and a markedly reduced Bax activation (21.5 and 16.6%) (Figure 3c ). These findings demonstrate that Bax-dependent activation of the mitochondrial apoptotic pathway following IL-3 deprivation was altered in cyclin D1-producing cells.
Molecular chaperones are overexpressed in BD1-A21 cells Proteomes of both cell lines were analysed by 2D electrophoresis to identify proteins deregulated by cyclin D1 (Figure 4a ). Nineteen spots showed a higher relative abundance (>2-fold) in the BD1-A21 electrophoregram than in the BaF3 electrophoregram. These spots were analysed by liquid chromatography electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS) and the corresponding proteins were unambiguously identified (Table 1) . We determined the different isoforms of a number of protein spots by sequencing specific peptides. For example, spot no. 12 was identified as the NP_775550 protein, which exists as three spliced isoforms; sequencing of the peptide SHEGETAYIR (positions 182-191) showed that this spot corresponded to the spliced isoform 1 of the protein. Spots 12, 18, 19 and 20 each contained two proteins.
Several proteins identified with a high relative abundance in BD1-A21 are involved in either cellular metabolism (3-phosphoglycerate dehydrogenase and pyrophosphatase (spots 6 and 10), protein translation (eukaryotic translation elongation factor 1 and eukaryotic translation initiation factor 5 (spots 11 and 17), or in intracellular signalling (Rho GDP-dissociation inhibitor 1 and 2 (spots 13 and 14). Several spots corresponded to molecular chaperones. Two were identified as the constitutive heat shock cognate 71 kDa (70 kDa Hsp8/Hsc70: spots 2 and 3) that belongs to the Hsp70 family; two others were endoplasmic reticulum-related chaperones: the Hsp90 homolog gp96/ GRP94 or Hsp96 and calreticulin (spots 1 and 8, respectively); one was the mitochondrial Hsp60 (chaperonin, spot 5) and another was thioredoxin 1 (spot 19). Additionally, the transcription factor, CCAAT/enhancer binding protein-b (C/EPBb)-whose interdependency with cyclin D1 affects Hsps levels -was identified in BD1-A21, but not BaF3 cells (Figure 4b ). Relative amounts of the major Hsp proteins were determined in the two cell lines by standard immunoblotting using b-tubulin as a reference. Consistent with two-dimensional data, levels of Hsp90 and Hsp27 were similar in the two cell lines; the amount of Hsp70 was slightly but reproducibly increased in BD1-A21 (Figure 4c , data not shown).
Increased Hsp70 chaperoning activity leads to delayed apoptosis in BD1-A21 cells Expression profiles of cyclin D1 target genes in breast cancer cells highlighted a major role of Hsp70, an antiapoptotic chaperone (Beere, 2001) . To test whether Hsp70 was involved in BD1-A21 resistance to IL-3 withdrawal, BaF3 and BD1-A21 cells were cultured for 24 h in the absence of IL-3. Hsp70 complexes were immunoprecipitated and analysed for the presence of Hsp70-client proteins, Bax and AIF. Analysis of the immunoprecipitated (bound) fraction of unstimulated ( þ IL-3) cells revealed that substantial amounts of Bax but not AIF were associated with the chaperone in BD1-A21, but not BaF3, cells (Figure 5a ). Consequently, Bax protein levels in the corresponding free (unbound) fraction were lower in BD1-A21 cells than in the parental cell line. After IL-3 withdrawal (ÀIL-3), Bax and AIF levels were similar in both cell lines (lysates). However, whereas some of these proteins still interacted with Hsp70 in BaF3 cells, greater amounts of both factors were precipitated with the chaperone in BD1-A21 cells. Therefore, the reduced levels of Bax and AIF in the Hsp70-unbound fraction indicated smaller amounts of these proteins were being released into the cytosol, where they participate in regulating apoptosis. The reciprocal immunoprecipitation of Bax-dependent complexes confirmed the specificity of the Hsp70-Bax interaction in BD1-A21 cells cultured with or without IL-3, and showed that AIF and Bax were not in the same complexes in these cells (Figure 5a ). Therefore, these findings suggest that increased Hsp70 chaperoning of Bax and AIF may be involved in delaying the induction of apoptosis after IL-3 withdrawal in BD1-A21 cells. To further assess this possibility, BD1-A21 cells were pretreated for 1 h with increasing concentrations of the pharmacological Hsp inhibitor KNK437 (Yokota et al., 2000) before 24 h culture in the absence or presence of IL-3. KNK437 was not cytotoxic in control ( þ IL-3) BD1-A21 cells, using a range of concentrations between 1 and 50 mM (Figure 5b ). The staining intensity of this spot did not vary in BD1-A21 cells.
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However, in the absence of IL-3, it restored mitochondrial depolarization (Figure 5b ), to the levels observed in BaF3 cells (Figure 3c ). Immunoprecipitation analysis of Hsp70 complexes showed that this sensitizing effect of KNK437 was consistent with its dose-dependent inhibition of the interaction between the chaperone and both Bax and AIF in IL-3-starved BD1-A21 cells, and its small effect on these interactions in control cells (Figure 5c ). The consequent accumulation of both pro-apoptotic factors in the free, unbound fraction may underlie the greater response of BD1-A21 cells to IL-3 withdrawal. Moreover, the introduction of a blocking anti-Hsp70 antibody in BD1-A21 cells at least partially restored Bax conformational activation and Cyclin D1 regulation of apoptosis G Roué et al mitochondrial depolarization following IL-3 withdrawal (Figure 5d ; compare Figures 3c and 5d ). These findings strongly suggest a cytoprotective role of Hsp70 against the activation of the mitochondrial apoptotic pathway induced by cytokine deprivation in cyclin D1-producing cells.
Hsp70 stabilizes NF-kB anti-apoptotic target genes in cyclin D1-producing cells We compared the levels of B-cell-specific Bcl-2 family members and intracellular caspase antagonists of the inhibitors of apoptosis (IAPs) family in BaF3 and BD1-A21 cells, to determine whether additional antiapoptotic factors may be associated with Hsp70 in cyclin D1-expressing cells. Several factors were either exclusively present (c-IAP-1, survivin dimers) or overproduced (c-IAP-2, survivin monomers, Fas-associated death domain-like IL-1b-converting enzyme inhibitory protein (FLIP), Bcl-xL) in BD1-A21 cells (Figure 6a ). Other anti-apoptotic proteins such as Mcl-1, Bim or X chromosome-linked IAP were present at similar levels in both cell lines (data not shown). Interestingly, all the proteins that were overproduced by cyclin D1-expressing cells are regulated by NF-kB transcriptional activity and are involved in NF-kB-dependent anti-apoptotic signalling in B cells (Burstein and Duckett, 2003) . We investigated the DNA-binding properties of the five NF-kB factors p65, p50, p52, c-Rel and RelB in BD1-A21 and BaF3 cells to elucidate the role of the NF-kB pathway. All factors, except p52, were constitutively activated in BaF3 and BD1-A21 cells. DNA-binding activity levels for p50 and c-Rel were slightly higher in BD1-A21 than BaF3 cells (Figure 6b ). Accordingly, western blot analysis of the phosphorylated and inactive forms of the intracellular NF-kB inhibitor (phospho-IkB) revealed higher amounts of the protein in BD1-A21 cells than BaF3 (Figure 6c ). Immunoprecipitation of Hsp70 in both cell lines showed higher basal levels of phospho-IkB bound to Hsp70 and lower levels in the Hsp70 unbound, free fraction in the BD1-A21 cell line than in parental BaF3 cells (Figure 6d) . Thus, accumulation of Hsp70 in cyclin D1-producing cells led to a higher level of association between the chaperone protein and IkB, allowing p50 and c-Rel de-repression, and consequent activation of some of their anti-apoptotic target genes. 
Discussion
Altered levels of cyclin D1 are associated with tumourigenesis . Several studies have used experimental models to demonstrate a link between cyclin D1 and a reduced cell response to cytotoxic drugs, including the DNA replication inhibitor methotrexate (Hochhauser et al., 1996) , the topoisomerase II inhibitors mitoxantrone and Etop (Kornmann et al., 1999; Kuhn et al., 2003) , and the protein kinase inhibitor STS (Orr et al., 1998) ; whereas, cell sensitivity to the DNA cross-linker cisplatin or to the DNA-intercalating agent Dox seem to be uncorrelated to cyclin D1 levels (Hochhauser et al., 1996; Bible et al., 2000) . In sharp contrast, high ectopic levels of cyclin D1 in mammary epithelial cells and breast tumour cell lines markedly increase cell sensitivity to apoptosis induced by various agents (Han et al., 1996; Coco Martin et al., 1999; Niu et al., 2001) . These discrepant observations may be due to the elevated and persistent production of cyclin D1 in some of these models, promoting apoptosis induction (Duquesne et al., 2001) , and the functional regulation of the tumour suppressor protein BRCA1 by cyclin D1/ CDK4 complexes (Kehn et al., 2007) . Using an original model of ectopic cyclin D1 production in the pre-B cell line BaF3, we reproduced a similar pattern of sensitivity/resistance to most of these anti-cancer drugs. The cyclin D1-producing BD1-A21 cell line had marked resistance to Etop-and STS-induced apoptosis, but was still sensitive to other agents. The mechanisms underlying the selective effects of cyclin D1 on cytotoxic druginduced signalling remains unclear. In cells exposed to osmotic and oxidative stresses, cyclin D1 phosphorylation, degradation and consequent G 1 arrest is a prerequisite to cell death (Agami and Bernards, 2000; Casanovas et al., 2000) . However, we showed that apoptosis following Etop or STS treatment was delayed due to defective processing in cyclin D1-producing cells, with no defect of cell-cycle arrest at the G 1 phase. In BD1-A21 cells, cyclin D1 did not alter cell proliferation, G 1 phase progression, levels of cyclins or CDKs, or cell sensitivity to the CDK inhibitor Flavo, consistent with previous findings (Bible et al., 2000) . In addition, STS treatment did not affect CDK2/4 levels in either BaF3, or BD1-A21 cell lines, despite their marked sensitivity to this kinase inhibitor (data not shown). Together, these findings suggest that a CDK-independent mechanism is involved in the cyclin D1 cytoprotective effect against apoptotic stimuli. Consistent with this, accumulating evidence from invitro studies and analyses of human tumours suggests that cyclin D1 may promote tumourigenesis by regulating the activity of several transcription factors in a CDK-independent manner (Ewen and Lamb, 2004) . For example, the functional interaction between cyclin D1 and the STAT3 target gene C/EBPb-deregulation of which has been implicated in the development of cancers (Zahnow, 2002) -activates an oncogenic axis principally involving a group of molecular chaperones (Lamb and Ewen, 2003) . Some important house-keeping functions attributed to this class of proteins include intercompartment import, correct folding, control of activity, degradation and prevention of aggregation of their client proteins (Macario and Conway de Macario, 2007) . Therefore, altered chaperone function contributes to tumour cell proliferation, differentiation, invasion, metastasis and recognition by the immune system (Ciocca and Calderwood, 2005; Calderwood et al., 2006) . We demonstrated in this study that the presence of cyclin D1 is accompanied by the induction of C/EBPb in BD1-A21 cells, and that 5 out of 19 proteins overproduced in these cells correspond to molecular chaperones (Hsp96, Hsc70, Hsp60, calreticulin, thioredoxin). Most harbour anti-apoptotic activities; in particular, the Hsps can directly regulate the activity of intracellular apoptosis signalling molecules (Beere, 2001) . Indeed, Hsp70 inhibits the mitochondrial translocation of Bax (Gotoh et al., 2004) , the nuclear translocation of AIF (Ruchalski et al., 2006) and apoptosome formation (Saleh et al., 2000) , although inhibition of apoptosome formation has not been confirmed in other models (Steel et al., 2004) . Hsc70 interacts with the Bcl-2 family member Bag-1, whereas Hsp60 interacts with Bad (Takayama et al., 1997; Stuart et al., 1998; Danial et al., 2003) . Calreticulin affects the p53-regulated apoptotic pathway, and thioredoxin affects phosphatase and tensin homolog signalling, to confer protection against oxidative stress (Andoh et al., 2002; Mesaeli and Phillipson, 2004) .
HSP70 is a major gene affected by cyclin D1 in human cancers , its promoter being activated independently of CDK activity (Kamano and Klempnauer, 1997) . Given its anti-apoptotic properties (Garrido et al., 2001 (Garrido et al., , 2006 , we examined a potential role of Hsp70 in the defective apoptotic signalling observed in BD1-A21 cells. Although Hsp70 levels were only moderately altered in BD1-A21 cells, Hsp70 interaction with Bax and AIF was enhanced, reducing the sensitivity of these cells to apoptosis following IL-3 withdrawal. We also demonstrated a direct effect of Hsp70 on the de-repression of NF-kB anti-apoptotic signalling. The NF-kB family of transcription factorsp65, p50, p52, c-Rel and RelB-is ubiquitously produced, p65/p50 being the predominant heterodimer. The p65/p50 complex is present in the cytoplasm, bound to a family of inhibitors of kB (IkB). IkB is phosphorylated by the IkB kinases following cell stimulation by certain inducers, and is degraded by the 26S proteasome. NF-kB then translocates to the nucleus, where it regulates the transcription of several genes encoding proteins implicated in both survival and apoptotic signalling pathways, such as FLIP, Bcl-2, Bcl-xL and members of the IAPs family (Ghosh and Karin, 2002) . We observed that accumulation of cyclin D1 and Hsp70 in BD1-A21 cells was associated with increased expression of some of these NF-kB target genes. Analysis of Hsp70-IkB interaction suggested that phospho-IkB is stabilized by the chaperone, impeding both phosphoIkB proteasomal degradation and its inhibition of the p50/c-Rel NF-kB complex. A role for Hsp70 in blocking phospho-IkB degradation has been previously described (Lee et al., 2005) .
In conclusion, this study describes the molecular chaperone Hsp70 as a possible mediator of the cyclin D1 cytoprotective effect against cell death triggered by certain drugs and growth factor deprivation. This involves Hsp70 chaperoning of both pro-apoptotic and anti-proliferative effectors. In light of a recent report on a cytoprotective role of Hsp70 in myeloma cells (Liu et al., 2006) , Hsp70 may be a new and attractive therapeutic target for the treatment of cyclin D1-producing B haemopathies.
Materials and methods
Cell culture and generation of BD1-A21 cell line The murine IL-3-dependent pro-B cell line BaF3 (Palacios and Steinmetz, 1985) and BD1 derivatives were cultured in a humid atmosphere at 37 1C in RPMI 1640 containing 10% foetal calf serum (FCS) and 5% WEHI-3B conditioned medium as a source of IL-3. The generation of cyclin D1-producing clones was previously described (Duquesne et al., 2001) .
Cell treatments
In IL-3 deprivation experiments, cells were washed twice and then cultured in RPMI containing 10% FCS. Anti-tumour drugs were purchased from Sigma-Aldrich (St Quentin Fallavier, France) and KNK437 (Hsp inhibitor I) from Calbiochem (Merck KGaA, Darmstadt, Germany). For induction of apoptosis with cytotoxic drugs, we performed pilot studies on BaF3 cells to determine the minimum concentration required to induce 50% of cell mortality after 24-48 h. Exponentially growing cells were treated with the various compounds, or with vehicle (ethanol or dimethylsulfoxide) for controls. Triplicate measurements were taken for each condition and each experiment was repeated at least twice.
Analysis of cell proliferation and apoptosis
Viable cells were counted in a haemocytometer by Trypan blue exclusion at different time intervals. Cell-cycle phases and subdiploid cell fractions were determined by flow cytometry after propidium iodide (PI)-staining of DNA as previously described (Duquesne et al., 2001) . PS exposure was quantified by double staining with Annexin V conjugated to fluorescein isothiocyanate and PI (BenderMedsystems, Vienna, Austria). Changes in mitochondrial transmembrane potential (DCm) were evaluated by staining cells with 20 nM DiOC 6 (3) (Molecular Probes, Invitrogen, Eugene, OR, USA). Bax conformational changes were determined by immunocytometry as previously described (Perez-Galan et al., 2006) . Ten thousand stained cells for each sample were acquired in a FACScan flow cytometer (Becton Dickinson, San Jose, CA, USA) using the Cellquest software (Becton Dickinson); data were analysed with ModFit LT 1.01 and Paint-A-Gate softwares (Becton Dickinson).
Immunoprecipitation and western blot assays Cells were lysed in CHAPS buffer (1% CHAPS 3-((3-cholamidopropyl)dimethylammonio)-1-propanesulphonate (w/v), 100 mM NaCl, 5 mM Na 3 PO 4 , 2.5 mM EDTA, 1 mg/ml leupeptin, 1 mg/ml aprotinin and 1 mM phenylmethylsulphonylfluoride). Protein extracts were pre-cleared by incubating 30 min with G-protein beads (Amersham Biosciences Europe GmbH, Saclay, France) and incubated overnight at 4 1C with anti-Hsp70 or anti-Bax antibody. G-protein beads were added for additional 1 h and supernatant (unbound fraction) was recovered by centrifugation. G-protein beads (bound fraction) were washed three times with CHAPS buffer. Reducing 5 Â sample buffer (400 mM Tris-HCl pH 6.8, 10% SDS, 50% glycerol, 500 mM dithiothreitol and 0.1% Bromophenol blue) was added to both fractions. Proteins were separated by SDSpolyacrylamide gel electrophoresis (PAGE) and subjected to western blot analysis as previously described (Duquesne et al., 2001) . Membranes were probed with the primary antibodies indicated. Antibody binding was detected using horseradish peroxidase-labelled secondary antibodies and the enhanced chemiluminescence detection system (Amersham Biosciences Europe GmbH). Densitometry analyses were performed with a FluorSImager using QuantityOne software (Bio-Rad).
2D gel electrophoresis, in-gel digestion and mass spectrometry Protein purification from BaF3 and BD1-A21 cells, isoelectric focusing and SDS-PAGE procedures for 2D electrophoresis were carried out as described previously (Le Moguen et al., 2006) . Protein spots were excised from Coomassie-stained gels and digested by trypsin as previously described (Sauvageot et al., 2002) . Digested peptides were re-suspended in 0.5% aqueous formic acid and analysed by high-performance liquid chromatography (Surveyor LC, Thermo Electron, Thermo Fischer Scientific, Cergy Pontoise Cedex, France) coupled online to an electrospray ion trap mass spectrometer (LCQ DECA XP, Thermo Electron). Peptides were loaded onto a 150 Â 0.5 mm C8 capillary column (Hypurity, Thermohypersil), and separated using a 30-min linear gradient (flow rate, 10 ml/min) from 5 to 60% of solvent B (0.1% formic acid in acetonitrile), where solvent A was 0.1% aqueous formic acid. The ionization parameters were set as previously described (Sauvageot et al., 2002) , and the LCQ was run in automatic mode, collecting a full MS scan (three 50-ms-microscans, m/z range 400-1600) followed by an MS/MS scan (two 400-ms-microscans, normalized collision energy 35%) of the highest intensity peptide with dynamic exclusion. Recorded MS/MS spectra were compared to theoretical values from a database of trypsin fragments (that is, IPI.mouse.v3.33, last downloaded from ftp://www.ebi.ac.uk on 09/2007), using the Sequest algorithm incorporated in the BioWorks software (v.2, Thermo Electron); oxidation of methionine and phosphorylation of serine, threonine or tyrosine were considered as different modifications.
Intracellular delivery of antibodies BD1-A21 cells were transfected with the anti-Hsp70 polyclonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) using the Chariot reagent (Active Motif, Rixensart, Belgium) according to manufacturer's recommendations. Briefly, 10 5 cells were washed once in phosphate-buffered saline, plated in 96-well plates and incubated for 1 h with a solution containing 0.5 ml Chariot reagent and Hsp70 antibody (final dilution 1/1000) in the absence of FCS. Cells were incubated for an additional 2 h in complete RPMI 1640 medium. Cells were then cultured for 24 h in the presence or absence of IL-3, and analysed as described for DiOC 6 (3) incorporation and Bax conformational activation.
NF-kB DNA-binding activity assay Nuclear extracts were prepared using the Nuclear Extraction Kit from Active Motif (Rixensart, Belgium). After quantification by Bradford assay, 3 mg protein aliquots were analysed for each condition by the TransAM NF-kB family assay according to supplier's recommendations (Active Motif). Each condition was assayed in triplicate and DNA binding was determined from optical density (OD) at 450 nm, using Raji cell extracts as a positive control.
